Transvascular and Interstitial Transport in Tumors
The advent of hybridoma technology and genetic engineering has led to a large scale production of monoclonal antibodies and other biologically useful molecules. Some of these molecules can bind to intra-or extracellular sites in tumors for detection and treatment, while others (e.g., lymphokines) have the ability to activate certain immune cells for killing cancer cells. Since these molecules or cells do not have the biological selectivity for tumors in vivo as previously envisioned, methods must be developed to deliver them selectively to the target in vivo. Since no molecule or cell can reach the tumor cells without passing through the vascular and interstitial compartments, it seems reasonable to find out more about the structure and function of these two compartments. In the past few years, we have focused our research on the experimental and mathematical characterization of transport through these spaces. I would like to share the results of some of these studies with you, and point out their implications for tumor growth, detection and treatment.
KeywordsConvective Velocity Fluorescence Recovery After Photobleaching Microvascular Permeability Increase Tumor Size Tumor Periphery
Unable to display preview. Download preview PDF.
- 1.F.E. Curry, Mechanics and thermodynamics of transcapiilary exchange. In “Handbook of Physiology — The Cardiovascular System — Microcirculation,” E.M. Renkin and C.C. Michel, eds, American Physiological Society, Bethesda, pp 309–374 (1984).Google Scholar
- 3.R.K. Jam, Transport of molecules in the tumor interstitium: A review. Cancer Research, 47:3038–3050 (1987).Google Scholar
- 11.L.E. Gerlowski and R.K. Jain, Effect of hyperthermia on microvascular permeability of normal and neoplastic tissues. International Journal of Microcirculation: Clinical and Experimental, 4:336–372 (1985).Google Scholar
- 12.H. Sezaki and M. Hashida, Macromolecule — drug conjugates in targeted cancer chemotherapy, CRC Critical Reviews on Therapeutic Drug Systems, 1:1–38 (1984).Google Scholar
- 13.G. Poste, Drug targeting in cancer therapy In: “Receptor-Mediated Targeting of Drugs,” G. Gregoriadis, G. Poste, J. Senior and A. Trouet, eds, Plenum, New York, pp. 427–474 (1985).Google Scholar
- 16.R.K. Jain and K.A. Ward-Hartley, Tumor blood flow: Characterization, modifications and role in hyperthermia, IEEE Transactions in Sonics and Ultrasonics; Special Issue on Hyperthermia, SU-31:504–526 (1984).Google Scholar
- 17.R.K. Jain and J. Wei, Dynamics of drug transport in solid tumors: Distributed parameter model,J. Bioengineering, 1:313–329 (1977).Google Scholar
- 18.R.K. Jain, Intersitital transport in tumors,Advances in Microcirculation. 13:266–284 (1987).Google Scholar
- 20.D.L. Taylor, A.S. Waggoner, R.F. Murphy, F. Lanni, and R.R. Birge, eds., “Applications of fluorescence in the biomedical sciences,” A.R. Liss, New York (1986).Google Scholar